nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—Mitomycin—stomach cancer	0.185	0.363	CbGbCtD
Etravirine—CYP2C9—Capecitabine—stomach cancer	0.079	0.155	CbGbCtD
Etravirine—ABCB4—bile—stomach cancer	0.0683	0.49	CbGeAlD
Etravirine—ABCB1—Irinotecan—stomach cancer	0.0474	0.0932	CbGbCtD
Etravirine—CYP2C9—Fluorouracil—stomach cancer	0.0469	0.0922	CbGbCtD
Etravirine—ABCB1—Docetaxel—stomach cancer	0.0347	0.0683	CbGbCtD
Etravirine—CYP3A4—Irinotecan—stomach cancer	0.0284	0.0558	CbGbCtD
Etravirine—ABCB1—Doxorubicin—stomach cancer	0.0259	0.0509	CbGbCtD
Etravirine—ABCB1—Methotrexate—stomach cancer	0.0251	0.0493	CbGbCtD
Etravirine—CYP3A4—Docetaxel—stomach cancer	0.0208	0.0409	CbGbCtD
Etravirine—ABCB4—gall bladder—stomach cancer	0.019	0.136	CbGeAlD
Etravirine—CYP3A4—Doxorubicin—stomach cancer	0.0155	0.0305	CbGbCtD
Etravirine—ABCB4—hematopoietic system—stomach cancer	0.0107	0.077	CbGeAlD
Etravirine—ABCB4—endocrine gland—stomach cancer	0.00617	0.0443	CbGeAlD
Etravirine—ABCB4—liver—stomach cancer	0.00556	0.0399	CbGeAlD
Etravirine—ABCB4—lymph node—stomach cancer	0.00426	0.0306	CbGeAlD
Etravirine—CYP2C19—hematopoietic system—stomach cancer	0.00253	0.0182	CbGeAlD
Etravirine—ABCB1—blood vessel—stomach cancer	0.00199	0.0143	CbGeAlD
Etravirine—CYP2C9—hematopoietic system—stomach cancer	0.00196	0.0141	CbGeAlD
Etravirine—CYP2C19—digestive system—stomach cancer	0.00176	0.0126	CbGeAlD
Etravirine—CYP3A4—hematopoietic system—stomach cancer	0.0015	0.0107	CbGeAlD
Etravirine—CYP2C19—endocrine gland—stomach cancer	0.00145	0.0104	CbGeAlD
Etravirine—CYP2C9—digestive system—stomach cancer	0.00137	0.0098	CbGeAlD
Etravirine—CYP2C19—liver—stomach cancer	0.00131	0.00941	CbGeAlD
Etravirine—CYP2C9—endocrine gland—stomach cancer	0.00113	0.0081	CbGeAlD
Etravirine—ABCB1—hematopoietic system—stomach cancer	0.00106	0.0076	CbGeAlD
Etravirine—CYP3A4—digestive system—stomach cancer	0.00104	0.00747	CbGeAlD
Etravirine—CYP2C9—liver—stomach cancer	0.00102	0.0073	CbGeAlD
Etravirine—ABCB1—epithelium—stomach cancer	0.000968	0.00695	CbGeAlD
Etravirine—ABCB1—pancreas—stomach cancer	0.000863	0.00619	CbGeAlD
Etravirine—CYP3A4—endocrine gland—stomach cancer	0.00086	0.00617	CbGeAlD
Etravirine—CYP3A4—liver—stomach cancer	0.000775	0.00557	CbGeAlD
Etravirine—ABCB1—lymphoid tissue—stomach cancer	0.000746	0.00535	CbGeAlD
Etravirine—ABCB1—digestive system—stomach cancer	0.000737	0.00529	CbGeAlD
Etravirine—ABCB1—bone marrow—stomach cancer	0.000679	0.00488	CbGeAlD
Etravirine—ABCB1—endocrine gland—stomach cancer	0.000609	0.00437	CbGeAlD
Etravirine—ABCB1—liver—stomach cancer	0.000549	0.00394	CbGeAlD
Etravirine—ABCB1—lymph node—stomach cancer	0.000421	0.00302	CbGeAlD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000321	0.00119	CcSEcCtD
Etravirine—Stomatitis—Epirubicin—stomach cancer	0.000319	0.00118	CcSEcCtD
Etravirine—Conjunctivitis—Epirubicin—stomach cancer	0.000318	0.00118	CcSEcCtD
Etravirine—Hypertension—Capecitabine—stomach cancer	0.000317	0.00117	CcSEcCtD
Etravirine—Hypersensitivity—Fluorouracil—stomach cancer	0.000316	0.00117	CcSEcCtD
Etravirine—Dry mouth—Docetaxel—stomach cancer	0.000316	0.00117	CcSEcCtD
Etravirine—Hepatitis—Methotrexate—stomach cancer	0.000314	0.00116	CcSEcCtD
Etravirine—Confusional state—Docetaxel—stomach cancer	0.000312	0.00115	CcSEcCtD
Etravirine—Anxiety—Capecitabine—stomach cancer	0.000312	0.00115	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00031	0.00115	CcSEcCtD
Etravirine—Urinary tract disorder—Methotrexate—stomach cancer	0.00031	0.00115	CcSEcCtD
Etravirine—Hepatobiliary disease—Epirubicin—stomach cancer	0.00031	0.00114	CcSEcCtD
Etravirine—Discomfort—Capecitabine—stomach cancer	0.000309	0.00114	CcSEcCtD
Etravirine—Urethral disorder—Methotrexate—stomach cancer	0.000308	0.00114	CcSEcCtD
Etravirine—Infection—Docetaxel—stomach cancer	0.000307	0.00114	CcSEcCtD
Etravirine—Hyperglycaemia—Doxorubicin—stomach cancer	0.000306	0.00113	CcSEcCtD
Etravirine—Diarrhoea—Irinotecan—stomach cancer	0.000306	0.00113	CcSEcCtD
Etravirine—Dry mouth—Capecitabine—stomach cancer	0.000306	0.00113	CcSEcCtD
Etravirine—Shock—Docetaxel—stomach cancer	0.000305	0.00113	CcSEcCtD
Etravirine—Nervous system disorder—Docetaxel—stomach cancer	0.000304	0.00112	CcSEcCtD
Etravirine—Thrombocytopenia—Docetaxel—stomach cancer	0.000303	0.00112	CcSEcCtD
Etravirine—Confusional state—Capecitabine—stomach cancer	0.000302	0.00112	CcSEcCtD
Etravirine—Skin disorder—Docetaxel—stomach cancer	0.000301	0.00111	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.0003	0.00111	CcSEcCtD
Etravirine—Renal failure—Doxorubicin—stomach cancer	0.000298	0.0011	CcSEcCtD
Etravirine—Infection—Capecitabine—stomach cancer	0.000298	0.0011	CcSEcCtD
Etravirine—Erythema multiforme—Methotrexate—stomach cancer	0.000297	0.0011	CcSEcCtD
Etravirine—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000297	0.0011	CcSEcCtD
Etravirine—Dizziness—Irinotecan—stomach cancer	0.000296	0.0011	CcSEcCtD
Etravirine—Stomatitis—Doxorubicin—stomach cancer	0.000295	0.00109	CcSEcCtD
Etravirine—Anorexia—Docetaxel—stomach cancer	0.000295	0.00109	CcSEcCtD
Etravirine—Shock—Capecitabine—stomach cancer	0.000295	0.00109	CcSEcCtD
Etravirine—Conjunctivitis—Doxorubicin—stomach cancer	0.000294	0.00109	CcSEcCtD
Etravirine—Nervous system disorder—Capecitabine—stomach cancer	0.000294	0.00109	CcSEcCtD
Etravirine—Hepatitis—Epirubicin—stomach cancer	0.000294	0.00109	CcSEcCtD
Etravirine—Eye disorder—Methotrexate—stomach cancer	0.000293	0.00109	CcSEcCtD
Etravirine—Diarrhoea—Fluorouracil—stomach cancer	0.000293	0.00109	CcSEcCtD
Etravirine—Thrombocytopenia—Capecitabine—stomach cancer	0.000293	0.00109	CcSEcCtD
Etravirine—Hypoaesthesia—Epirubicin—stomach cancer	0.000292	0.00108	CcSEcCtD
Etravirine—Cardiac disorder—Methotrexate—stomach cancer	0.000291	0.00108	CcSEcCtD
Etravirine—Skin disorder—Capecitabine—stomach cancer	0.000291	0.00108	CcSEcCtD
Etravirine—Urinary tract disorder—Epirubicin—stomach cancer	0.00029	0.00107	CcSEcCtD
Etravirine—Hyperhidrosis—Capecitabine—stomach cancer	0.00029	0.00107	CcSEcCtD
Etravirine—Connective tissue disorder—Epirubicin—stomach cancer	0.000289	0.00107	CcSEcCtD
Etravirine—Urethral disorder—Epirubicin—stomach cancer	0.000288	0.00107	CcSEcCtD
Etravirine—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000286	0.00106	CcSEcCtD
Etravirine—Anorexia—Capecitabine—stomach cancer	0.000286	0.00106	CcSEcCtD
Etravirine—Angiopathy—Methotrexate—stomach cancer	0.000285	0.00105	CcSEcCtD
Etravirine—Vomiting—Irinotecan—stomach cancer	0.000285	0.00105	CcSEcCtD
Etravirine—Immune system disorder—Methotrexate—stomach cancer	0.000284	0.00105	CcSEcCtD
Etravirine—Dizziness—Fluorouracil—stomach cancer	0.000284	0.00105	CcSEcCtD
Etravirine—Mediastinal disorder—Methotrexate—stomach cancer	0.000283	0.00105	CcSEcCtD
Etravirine—Rash—Irinotecan—stomach cancer	0.000282	0.00104	CcSEcCtD
Etravirine—Dermatitis—Irinotecan—stomach cancer	0.000282	0.00104	CcSEcCtD
Etravirine—Headache—Irinotecan—stomach cancer	0.00028	0.00104	CcSEcCtD
Etravirine—Insomnia—Docetaxel—stomach cancer	0.00028	0.00104	CcSEcCtD
Etravirine—Paraesthesia—Docetaxel—stomach cancer	0.000278	0.00103	CcSEcCtD
Etravirine—Erythema multiforme—Epirubicin—stomach cancer	0.000278	0.00103	CcSEcCtD
Etravirine—Somnolence—Docetaxel—stomach cancer	0.000275	0.00102	CcSEcCtD
Etravirine—Mental disorder—Methotrexate—stomach cancer	0.000275	0.00102	CcSEcCtD
Etravirine—Eye disorder—Epirubicin—stomach cancer	0.000275	0.00102	CcSEcCtD
Etravirine—Malnutrition—Methotrexate—stomach cancer	0.000273	0.00101	CcSEcCtD
Etravirine—Cardiac disorder—Epirubicin—stomach cancer	0.000273	0.00101	CcSEcCtD
Etravirine—Vomiting—Fluorouracil—stomach cancer	0.000273	0.00101	CcSEcCtD
Etravirine—Hepatitis—Doxorubicin—stomach cancer	0.000272	0.00101	CcSEcCtD
Etravirine—Insomnia—Capecitabine—stomach cancer	0.000271	0.001	CcSEcCtD
Etravirine—Hypoaesthesia—Doxorubicin—stomach cancer	0.000271	0.001	CcSEcCtD
Etravirine—Rash—Fluorouracil—stomach cancer	0.00027	0.001	CcSEcCtD
Etravirine—Dermatitis—Fluorouracil—stomach cancer	0.00027	0.000999	CcSEcCtD
Etravirine—Paraesthesia—Capecitabine—stomach cancer	0.000269	0.000995	CcSEcCtD
Etravirine—Decreased appetite—Docetaxel—stomach cancer	0.000269	0.000995	CcSEcCtD
Etravirine—Headache—Fluorouracil—stomach cancer	0.000269	0.000994	CcSEcCtD
Etravirine—Urinary tract disorder—Doxorubicin—stomach cancer	0.000269	0.000993	CcSEcCtD
Etravirine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000267	0.000988	CcSEcCtD
Etravirine—Connective tissue disorder—Doxorubicin—stomach cancer	0.000267	0.000988	CcSEcCtD
Etravirine—Fatigue—Docetaxel—stomach cancer	0.000267	0.000987	CcSEcCtD
Etravirine—Angiopathy—Epirubicin—stomach cancer	0.000267	0.000986	CcSEcCtD
Etravirine—Urethral disorder—Doxorubicin—stomach cancer	0.000267	0.000986	CcSEcCtD
Etravirine—Nausea—Irinotecan—stomach cancer	0.000266	0.000984	CcSEcCtD
Etravirine—Immune system disorder—Epirubicin—stomach cancer	0.000265	0.000982	CcSEcCtD
Etravirine—Mediastinal disorder—Epirubicin—stomach cancer	0.000265	0.000979	CcSEcCtD
Etravirine—Constipation—Docetaxel—stomach cancer	0.000265	0.000979	CcSEcCtD
Etravirine—Pain—Docetaxel—stomach cancer	0.000265	0.000979	CcSEcCtD
Etravirine—Decreased appetite—Capecitabine—stomach cancer	0.000261	0.000963	CcSEcCtD
Etravirine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000259	0.000957	CcSEcCtD
Etravirine—Fatigue—Capecitabine—stomach cancer	0.000258	0.000956	CcSEcCtD
Etravirine—Vision blurred—Methotrexate—stomach cancer	0.000258	0.000953	CcSEcCtD
Etravirine—Mental disorder—Epirubicin—stomach cancer	0.000257	0.000952	CcSEcCtD
Etravirine—Erythema multiforme—Doxorubicin—stomach cancer	0.000257	0.000951	CcSEcCtD
Etravirine—Pain—Capecitabine—stomach cancer	0.000256	0.000948	CcSEcCtD
Etravirine—Constipation—Capecitabine—stomach cancer	0.000256	0.000948	CcSEcCtD
Etravirine—Malnutrition—Epirubicin—stomach cancer	0.000256	0.000946	CcSEcCtD
Etravirine—Feeling abnormal—Docetaxel—stomach cancer	0.000255	0.000943	CcSEcCtD
Etravirine—Nausea—Fluorouracil—stomach cancer	0.000255	0.000942	CcSEcCtD
Etravirine—Eye disorder—Doxorubicin—stomach cancer	0.000254	0.00094	CcSEcCtD
Etravirine—Ill-defined disorder—Methotrexate—stomach cancer	0.000254	0.000938	CcSEcCtD
Etravirine—Gastrointestinal pain—Docetaxel—stomach cancer	0.000253	0.000936	CcSEcCtD
Etravirine—Anaemia—Methotrexate—stomach cancer	0.000253	0.000934	CcSEcCtD
Etravirine—Cardiac disorder—Doxorubicin—stomach cancer	0.000252	0.000933	CcSEcCtD
Etravirine—Flatulence—Epirubicin—stomach cancer	0.000252	0.000932	CcSEcCtD
Etravirine—Tension—Epirubicin—stomach cancer	0.000251	0.000928	CcSEcCtD
Etravirine—Nervousness—Epirubicin—stomach cancer	0.000248	0.000919	CcSEcCtD
Etravirine—Feeling abnormal—Capecitabine—stomach cancer	0.000247	0.000913	CcSEcCtD
Etravirine—Angiopathy—Doxorubicin—stomach cancer	0.000247	0.000912	CcSEcCtD
Etravirine—Malaise—Methotrexate—stomach cancer	0.000246	0.000912	CcSEcCtD
Etravirine—Immune system disorder—Doxorubicin—stomach cancer	0.000246	0.000908	CcSEcCtD
Etravirine—Vertigo—Methotrexate—stomach cancer	0.000246	0.000908	CcSEcCtD
Etravirine—Gastrointestinal pain—Capecitabine—stomach cancer	0.000245	0.000906	CcSEcCtD
Etravirine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000245	0.000906	CcSEcCtD
Etravirine—Body temperature increased—Docetaxel—stomach cancer	0.000245	0.000905	CcSEcCtD
Etravirine—Abdominal pain—Docetaxel—stomach cancer	0.000245	0.000905	CcSEcCtD
Etravirine—Vision blurred—Epirubicin—stomach cancer	0.000241	0.000892	CcSEcCtD
Etravirine—Mental disorder—Doxorubicin—stomach cancer	0.000238	0.000881	CcSEcCtD
Etravirine—Ill-defined disorder—Epirubicin—stomach cancer	0.000237	0.000878	CcSEcCtD
Etravirine—Abdominal pain—Capecitabine—stomach cancer	0.000237	0.000876	CcSEcCtD
Etravirine—Body temperature increased—Capecitabine—stomach cancer	0.000237	0.000876	CcSEcCtD
Etravirine—Convulsion—Methotrexate—stomach cancer	0.000237	0.000876	CcSEcCtD
Etravirine—Malnutrition—Doxorubicin—stomach cancer	0.000237	0.000875	CcSEcCtD
Etravirine—Anaemia—Epirubicin—stomach cancer	0.000236	0.000874	CcSEcCtD
Etravirine—Flatulence—Doxorubicin—stomach cancer	0.000233	0.000863	CcSEcCtD
Etravirine—Tension—Doxorubicin—stomach cancer	0.000232	0.000859	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000231	0.000855	CcSEcCtD
Etravirine—Malaise—Epirubicin—stomach cancer	0.000231	0.000853	CcSEcCtD
Etravirine—Discomfort—Methotrexate—stomach cancer	0.00023	0.00085	CcSEcCtD
Etravirine—Nervousness—Doxorubicin—stomach cancer	0.00023	0.00085	CcSEcCtD
Etravirine—Vertigo—Epirubicin—stomach cancer	0.00023	0.00085	CcSEcCtD
Etravirine—Syncope—Epirubicin—stomach cancer	0.000229	0.000848	CcSEcCtD
Etravirine—Hypersensitivity—Docetaxel—stomach cancer	0.000228	0.000843	CcSEcCtD
Etravirine—Confusional state—Methotrexate—stomach cancer	0.000225	0.000832	CcSEcCtD
Etravirine—Loss of consciousness—Epirubicin—stomach cancer	0.000225	0.000832	CcSEcCtD
Etravirine—Vision blurred—Doxorubicin—stomach cancer	0.000223	0.000825	CcSEcCtD
Etravirine—Asthenia—Docetaxel—stomach cancer	0.000222	0.000821	CcSEcCtD
Etravirine—Convulsion—Epirubicin—stomach cancer	0.000222	0.00082	CcSEcCtD
Etravirine—Infection—Methotrexate—stomach cancer	0.000222	0.00082	CcSEcCtD
Etravirine—Hypertension—Epirubicin—stomach cancer	0.000221	0.000817	CcSEcCtD
Etravirine—Hypersensitivity—Capecitabine—stomach cancer	0.000221	0.000817	CcSEcCtD
Etravirine—Ill-defined disorder—Doxorubicin—stomach cancer	0.00022	0.000812	CcSEcCtD
Etravirine—Nervous system disorder—Methotrexate—stomach cancer	0.000219	0.000809	CcSEcCtD
Etravirine—Anaemia—Doxorubicin—stomach cancer	0.000219	0.000809	CcSEcCtD
Etravirine—Thrombocytopenia—Methotrexate—stomach cancer	0.000218	0.000808	CcSEcCtD
Etravirine—Anxiety—Epirubicin—stomach cancer	0.000217	0.000803	CcSEcCtD
Etravirine—Skin disorder—Methotrexate—stomach cancer	0.000217	0.000801	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000216	0.0008	CcSEcCtD
Etravirine—Hyperhidrosis—Methotrexate—stomach cancer	0.000216	0.000798	CcSEcCtD
Etravirine—Discomfort—Epirubicin—stomach cancer	0.000215	0.000796	CcSEcCtD
Etravirine—Asthenia—Capecitabine—stomach cancer	0.000215	0.000795	CcSEcCtD
Etravirine—Malaise—Doxorubicin—stomach cancer	0.000213	0.000789	CcSEcCtD
Etravirine—Dry mouth—Epirubicin—stomach cancer	0.000213	0.000788	CcSEcCtD
Etravirine—Vertigo—Doxorubicin—stomach cancer	0.000213	0.000786	CcSEcCtD
Etravirine—Anorexia—Methotrexate—stomach cancer	0.000213	0.000786	CcSEcCtD
Etravirine—Syncope—Doxorubicin—stomach cancer	0.000212	0.000785	CcSEcCtD
Etravirine—Diarrhoea—Docetaxel—stomach cancer	0.000212	0.000783	CcSEcCtD
Etravirine—Confusional state—Epirubicin—stomach cancer	0.000211	0.000779	CcSEcCtD
Etravirine—Loss of consciousness—Doxorubicin—stomach cancer	0.000208	0.000769	CcSEcCtD
Etravirine—Infection—Epirubicin—stomach cancer	0.000207	0.000767	CcSEcCtD
Etravirine—Shock—Epirubicin—stomach cancer	0.000205	0.00076	CcSEcCtD
Etravirine—Convulsion—Doxorubicin—stomach cancer	0.000205	0.000758	CcSEcCtD
Etravirine—Diarrhoea—Capecitabine—stomach cancer	0.000205	0.000758	CcSEcCtD
Etravirine—Nervous system disorder—Epirubicin—stomach cancer	0.000205	0.000757	CcSEcCtD
Etravirine—Dizziness—Docetaxel—stomach cancer	0.000205	0.000757	CcSEcCtD
Etravirine—Thrombocytopenia—Epirubicin—stomach cancer	0.000204	0.000756	CcSEcCtD
Etravirine—Hypertension—Doxorubicin—stomach cancer	0.000204	0.000756	CcSEcCtD
Etravirine—Skin disorder—Epirubicin—stomach cancer	0.000203	0.00075	CcSEcCtD
Etravirine—Hyperhidrosis—Epirubicin—stomach cancer	0.000202	0.000746	CcSEcCtD
Etravirine—Insomnia—Methotrexate—stomach cancer	0.000202	0.000746	CcSEcCtD
Etravirine—Anxiety—Doxorubicin—stomach cancer	0.000201	0.000743	CcSEcCtD
Etravirine—Paraesthesia—Methotrexate—stomach cancer	0.0002	0.000741	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.0002	0.00074	CcSEcCtD
Etravirine—Discomfort—Doxorubicin—stomach cancer	0.000199	0.000736	CcSEcCtD
Etravirine—Anorexia—Epirubicin—stomach cancer	0.000199	0.000736	CcSEcCtD
Etravirine—Somnolence—Methotrexate—stomach cancer	0.000198	0.000733	CcSEcCtD
Etravirine—Dizziness—Capecitabine—stomach cancer	0.000198	0.000733	CcSEcCtD
Etravirine—Dry mouth—Doxorubicin—stomach cancer	0.000197	0.000729	CcSEcCtD
Etravirine—Vomiting—Docetaxel—stomach cancer	0.000197	0.000728	CcSEcCtD
Etravirine—Rash—Docetaxel—stomach cancer	0.000195	0.000722	CcSEcCtD
Etravirine—Dermatitis—Docetaxel—stomach cancer	0.000195	0.000721	CcSEcCtD
Etravirine—Confusional state—Doxorubicin—stomach cancer	0.000195	0.00072	CcSEcCtD
Etravirine—Decreased appetite—Methotrexate—stomach cancer	0.000194	0.000717	CcSEcCtD
Etravirine—Headache—Docetaxel—stomach cancer	0.000194	0.000717	CcSEcCtD
Etravirine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000193	0.000712	CcSEcCtD
Etravirine—Fatigue—Methotrexate—stomach cancer	0.000192	0.000711	CcSEcCtD
Etravirine—Infection—Doxorubicin—stomach cancer	0.000192	0.00071	CcSEcCtD
Etravirine—Pain—Methotrexate—stomach cancer	0.000191	0.000706	CcSEcCtD
Etravirine—Vomiting—Capecitabine—stomach cancer	0.000191	0.000705	CcSEcCtD
Etravirine—Shock—Doxorubicin—stomach cancer	0.00019	0.000703	CcSEcCtD
Etravirine—Nervous system disorder—Doxorubicin—stomach cancer	0.000189	0.000701	CcSEcCtD
Etravirine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000189	0.000699	CcSEcCtD
Etravirine—Rash—Capecitabine—stomach cancer	0.000189	0.000699	CcSEcCtD
Etravirine—Insomnia—Epirubicin—stomach cancer	0.000189	0.000698	CcSEcCtD
Etravirine—Dermatitis—Capecitabine—stomach cancer	0.000189	0.000698	CcSEcCtD
Etravirine—Headache—Capecitabine—stomach cancer	0.000188	0.000694	CcSEcCtD
Etravirine—Skin disorder—Doxorubicin—stomach cancer	0.000188	0.000694	CcSEcCtD
Etravirine—Paraesthesia—Epirubicin—stomach cancer	0.000187	0.000693	CcSEcCtD
Etravirine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000187	0.000691	CcSEcCtD
Etravirine—Somnolence—Epirubicin—stomach cancer	0.000186	0.000686	CcSEcCtD
Etravirine—Anorexia—Doxorubicin—stomach cancer	0.000184	0.000681	CcSEcCtD
Etravirine—Nausea—Docetaxel—stomach cancer	0.000184	0.00068	CcSEcCtD
Etravirine—Feeling abnormal—Methotrexate—stomach cancer	0.000184	0.00068	CcSEcCtD
Etravirine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000182	0.000675	CcSEcCtD
Etravirine—Decreased appetite—Epirubicin—stomach cancer	0.000181	0.000671	CcSEcCtD
Etravirine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00018	0.000667	CcSEcCtD
Etravirine—Fatigue—Epirubicin—stomach cancer	0.00018	0.000666	CcSEcCtD
Etravirine—Pain—Epirubicin—stomach cancer	0.000179	0.00066	CcSEcCtD
Etravirine—Constipation—Epirubicin—stomach cancer	0.000179	0.00066	CcSEcCtD
Etravirine—Nausea—Capecitabine—stomach cancer	0.000178	0.000658	CcSEcCtD
Etravirine—Abdominal pain—Methotrexate—stomach cancer	0.000176	0.000652	CcSEcCtD
Etravirine—Body temperature increased—Methotrexate—stomach cancer	0.000176	0.000652	CcSEcCtD
Etravirine—Insomnia—Doxorubicin—stomach cancer	0.000175	0.000646	CcSEcCtD
Etravirine—Paraesthesia—Doxorubicin—stomach cancer	0.000173	0.000642	CcSEcCtD
Etravirine—Feeling abnormal—Epirubicin—stomach cancer	0.000172	0.000636	CcSEcCtD
Etravirine—Somnolence—Doxorubicin—stomach cancer	0.000172	0.000635	CcSEcCtD
Etravirine—Gastrointestinal pain—Epirubicin—stomach cancer	0.000171	0.000631	CcSEcCtD
Etravirine—Decreased appetite—Doxorubicin—stomach cancer	0.000168	0.000621	CcSEcCtD
Etravirine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000167	0.000617	CcSEcCtD
Etravirine—Fatigue—Doxorubicin—stomach cancer	0.000167	0.000616	CcSEcCtD
Etravirine—Constipation—Doxorubicin—stomach cancer	0.000165	0.000611	CcSEcCtD
Etravirine—Pain—Doxorubicin—stomach cancer	0.000165	0.000611	CcSEcCtD
Etravirine—Abdominal pain—Epirubicin—stomach cancer	0.000165	0.00061	CcSEcCtD
Etravirine—Body temperature increased—Epirubicin—stomach cancer	0.000165	0.00061	CcSEcCtD
Etravirine—Hypersensitivity—Methotrexate—stomach cancer	0.000164	0.000608	CcSEcCtD
Etravirine—Asthenia—Methotrexate—stomach cancer	0.00016	0.000592	CcSEcCtD
Etravirine—Feeling abnormal—Doxorubicin—stomach cancer	0.000159	0.000589	CcSEcCtD
Etravirine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000158	0.000584	CcSEcCtD
Etravirine—Hypersensitivity—Epirubicin—stomach cancer	0.000154	0.000569	CcSEcCtD
Etravirine—Abdominal pain—Doxorubicin—stomach cancer	0.000153	0.000565	CcSEcCtD
Etravirine—Body temperature increased—Doxorubicin—stomach cancer	0.000153	0.000565	CcSEcCtD
Etravirine—Diarrhoea—Methotrexate—stomach cancer	0.000153	0.000565	CcSEcCtD
Etravirine—Asthenia—Epirubicin—stomach cancer	0.00015	0.000554	CcSEcCtD
Etravirine—Dizziness—Methotrexate—stomach cancer	0.000148	0.000546	CcSEcCtD
Etravirine—Diarrhoea—Epirubicin—stomach cancer	0.000143	0.000528	CcSEcCtD
Etravirine—Hypersensitivity—Doxorubicin—stomach cancer	0.000142	0.000526	CcSEcCtD
Etravirine—Vomiting—Methotrexate—stomach cancer	0.000142	0.000525	CcSEcCtD
Etravirine—Rash—Methotrexate—stomach cancer	0.000141	0.00052	CcSEcCtD
Etravirine—Dermatitis—Methotrexate—stomach cancer	0.000141	0.00052	CcSEcCtD
Etravirine—Headache—Methotrexate—stomach cancer	0.00014	0.000517	CcSEcCtD
Etravirine—Asthenia—Doxorubicin—stomach cancer	0.000139	0.000513	CcSEcCtD
Etravirine—Dizziness—Epirubicin—stomach cancer	0.000138	0.000511	CcSEcCtD
Etravirine—Vomiting—Epirubicin—stomach cancer	0.000133	0.000491	CcSEcCtD
Etravirine—Nausea—Methotrexate—stomach cancer	0.000133	0.00049	CcSEcCtD
Etravirine—Diarrhoea—Doxorubicin—stomach cancer	0.000132	0.000489	CcSEcCtD
Etravirine—Rash—Epirubicin—stomach cancer	0.000132	0.000487	CcSEcCtD
Etravirine—Dermatitis—Epirubicin—stomach cancer	0.000132	0.000486	CcSEcCtD
Etravirine—Headache—Epirubicin—stomach cancer	0.000131	0.000484	CcSEcCtD
Etravirine—Dizziness—Doxorubicin—stomach cancer	0.000128	0.000472	CcSEcCtD
Etravirine—Nausea—Epirubicin—stomach cancer	0.000124	0.000459	CcSEcCtD
Etravirine—Vomiting—Doxorubicin—stomach cancer	0.000123	0.000454	CcSEcCtD
Etravirine—Rash—Doxorubicin—stomach cancer	0.000122	0.00045	CcSEcCtD
Etravirine—Dermatitis—Doxorubicin—stomach cancer	0.000122	0.00045	CcSEcCtD
Etravirine—Headache—Doxorubicin—stomach cancer	0.000121	0.000448	CcSEcCtD
Etravirine—Nausea—Doxorubicin—stomach cancer	0.000115	0.000424	CcSEcCtD
Etravirine—CYP2C9—Biological oxidations—GSTM1—stomach cancer	6.83e-05	0.000833	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	6.8e-05	0.000829	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—GSTM1—stomach cancer	6.73e-05	0.000821	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	6.7e-05	0.000818	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	6.44e-05	0.000785	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ACAD8—stomach cancer	6.39e-05	0.000779	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	6.35e-05	0.000775	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ALB—stomach cancer	6.26e-05	0.000763	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GMPR2—stomach cancer	6.24e-05	0.000762	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	6.24e-05	0.000761	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GMPR2—stomach cancer	6.09e-05	0.000743	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—VEGFA—stomach cancer	6.05e-05	0.000738	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	6.03e-05	0.000735	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—NOS3—stomach cancer	5.99e-05	0.00073	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—RORA—stomach cancer	5.95e-05	0.000726	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	5.87e-05	0.000716	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—IDH3B—stomach cancer	5.71e-05	0.000697	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SUCLG1—stomach cancer	5.71e-05	0.000697	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GMPR2—stomach cancer	5.69e-05	0.000694	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SUCLG1—stomach cancer	5.57e-05	0.00068	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—IDH3B—stomach cancer	5.57e-05	0.00068	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	5.49e-05	0.00067	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PTGS2—stomach cancer	5.47e-05	0.000668	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—RORA—stomach cancer	5.43e-05	0.000662	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NDUFV1—stomach cancer	5.31e-05	0.000648	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NDUFS1—stomach cancer	5.31e-05	0.000648	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	5.3e-05	0.000647	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SUCLG1—stomach cancer	5.21e-05	0.000635	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—IDH3B—stomach cancer	5.21e-05	0.000635	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	5.19e-05	0.000633	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—TNF—stomach cancer	5.18e-05	0.000632	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NDUFV1—stomach cancer	5.18e-05	0.000632	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NDUFS1—stomach cancer	5.18e-05	0.000632	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	4.99e-05	0.000609	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTP1—stomach cancer	4.9e-05	0.000598	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NDUFS1—stomach cancer	4.84e-05	0.00059	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NDUFV1—stomach cancer	4.84e-05	0.00059	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	4.83e-05	0.000589	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PGLS—stomach cancer	4.73e-05	0.000577	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—BLVRB—stomach cancer	4.73e-05	0.000577	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	4.73e-05	0.000577	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	4.65e-05	0.000567	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PGLS—stomach cancer	4.62e-05	0.000563	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—BLVRB—stomach cancer	4.62e-05	0.000563	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPAP2A—stomach cancer	4.51e-05	0.000551	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTM1—stomach cancer	4.5e-05	0.000549	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	4.44e-05	0.000542	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPAP2A—stomach cancer	4.4e-05	0.000537	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	4.34e-05	0.000529	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PGLS—stomach cancer	4.31e-05	0.000526	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—BLVRB—stomach cancer	4.31e-05	0.000526	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ACAD8—stomach cancer	4.21e-05	0.000514	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPAP2A—stomach cancer	4.11e-05	0.000502	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CKB—stomach cancer	4.02e-05	0.000491	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CA1—stomach cancer	4.02e-05	0.000491	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—FBP1—stomach cancer	4.02e-05	0.000491	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NDUFA2—stomach cancer	4.02e-05	0.000491	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	3.96e-05	0.000483	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—FBP1—stomach cancer	3.93e-05	0.000479	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NDUFA2—stomach cancer	3.93e-05	0.000479	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CA1—stomach cancer	3.93e-05	0.000479	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CKB—stomach cancer	3.93e-05	0.000479	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	3.87e-05	0.000473	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	3.79e-05	0.000462	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PLIN2—stomach cancer	3.78e-05	0.000461	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GMPR2—stomach cancer	3.75e-05	0.000458	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PLIN2—stomach cancer	3.69e-05	0.00045	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CA2—stomach cancer	3.68e-05	0.000449	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CA1—stomach cancer	3.67e-05	0.000447	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—FBP1—stomach cancer	3.67e-05	0.000447	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NDUFA2—stomach cancer	3.67e-05	0.000447	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CKB—stomach cancer	3.67e-05	0.000447	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CA2—stomach cancer	3.59e-05	0.000438	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	3.59e-05	0.000438	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PGAM1—stomach cancer	3.59e-05	0.000437	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NT5E—stomach cancer	3.59e-05	0.000437	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PGAM1—stomach cancer	3.5e-05	0.000427	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NT5E—stomach cancer	3.5e-05	0.000427	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLIN2—stomach cancer	3.45e-05	0.000421	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SUCLG1—stomach cancer	3.43e-05	0.000419	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—IDH3B—stomach cancer	3.43e-05	0.000419	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	3.42e-05	0.000418	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALDH7A1—stomach cancer	3.42e-05	0.000417	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PLCE1—stomach cancer	3.42e-05	0.000417	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	3.42e-05	0.000417	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CA—stomach cancer	3.37e-05	0.000411	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CA2—stomach cancer	3.35e-05	0.000409	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALDH7A1—stomach cancer	3.34e-05	0.000407	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PLCE1—stomach cancer	3.34e-05	0.000407	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	3.31e-05	0.000404	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—UMPS—stomach cancer	3.28e-05	0.0004	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NT5E—stomach cancer	3.27e-05	0.000399	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PGAM1—stomach cancer	3.27e-05	0.000399	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	3.23e-05	0.000394	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—UMPS—stomach cancer	3.2e-05	0.00039	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NDUFV1—stomach cancer	3.19e-05	0.000389	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NDUFS1—stomach cancer	3.19e-05	0.000389	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALDH7A1—stomach cancer	3.12e-05	0.00038	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLCE1—stomach cancer	3.12e-05	0.00038	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PDHA1—stomach cancer	3.05e-05	0.000372	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ECHS1—stomach cancer	3.05e-05	0.000372	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—UMPS—stomach cancer	2.99e-05	0.000365	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	2.98e-05	0.000364	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PDHA1—stomach cancer	2.98e-05	0.000363	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ECHS1—stomach cancer	2.98e-05	0.000363	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TYMP—stomach cancer	2.87e-05	0.00035	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—FADS1—stomach cancer	2.87e-05	0.00035	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.86e-05	0.000349	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PGLS—stomach cancer	2.84e-05	0.000347	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—BLVRB—stomach cancer	2.84e-05	0.000347	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	2.82e-05	0.000344	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TYMP—stomach cancer	2.8e-05	0.000341	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—FADS1—stomach cancer	2.8e-05	0.000341	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PDHA1—stomach cancer	2.78e-05	0.000339	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ECHS1—stomach cancer	2.78e-05	0.000339	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2.75e-05	0.000335	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPAP2A—stomach cancer	2.71e-05	0.000331	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	2.69e-05	0.000328	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	2.69e-05	0.000328	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SREBF2—stomach cancer	2.68e-05	0.000327	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—RORA—stomach cancer	2.65e-05	0.000324	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SREBF2—stomach cancer	2.62e-05	0.00032	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TYMP—stomach cancer	2.61e-05	0.000319	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—FADS1—stomach cancer	2.61e-05	0.000319	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—RORA—stomach cancer	2.59e-05	0.000316	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.56e-05	0.000312	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.54e-05	0.000309	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALDOB—stomach cancer	2.48e-05	0.000303	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SREBF2—stomach cancer	2.45e-05	0.000299	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALDOB—stomach cancer	2.43e-05	0.000296	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NDUFA2—stomach cancer	2.42e-05	0.000295	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—FBP1—stomach cancer	2.42e-05	0.000295	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CKB—stomach cancer	2.42e-05	0.000295	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CA1—stomach cancer	2.42e-05	0.000295	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—RORA—stomach cancer	2.42e-05	0.000295	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.34e-05	0.000286	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.34e-05	0.000285	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	2.33e-05	0.000284	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALOX5—stomach cancer	2.31e-05	0.000282	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLIN2—stomach cancer	2.27e-05	0.000277	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—DPYD—stomach cancer	2.27e-05	0.000277	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALDOB—stomach cancer	2.27e-05	0.000276	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALOX5—stomach cancer	2.25e-05	0.000275	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	2.25e-05	0.000275	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—DPYD—stomach cancer	2.22e-05	0.000271	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CA2—stomach cancer	2.21e-05	0.00027	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	2.17e-05	0.000265	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NT5E—stomach cancer	2.16e-05	0.000263	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PGAM1—stomach cancer	2.16e-05	0.000263	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.14e-05	0.000261	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.13e-05	0.00026	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALOX5—stomach cancer	2.11e-05	0.000257	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—DPYD—stomach cancer	2.07e-05	0.000253	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.06e-05	0.000251	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLCE1—stomach cancer	2.06e-05	0.000251	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.06e-05	0.000251	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTT1—stomach cancer	2.01e-05	0.000245	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2A6—stomach cancer	1.99e-05	0.000242	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—UMPS—stomach cancer	1.97e-05	0.000241	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTT1—stomach cancer	1.96e-05	0.000239	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2A6—stomach cancer	1.94e-05	0.000237	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKR1C3—stomach cancer	1.93e-05	0.000236	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKR1C3—stomach cancer	1.89e-05	0.00023	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ENO1—stomach cancer	1.88e-05	0.00023	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.88e-05	0.000229	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.85e-05	0.000226	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ENO1—stomach cancer	1.84e-05	0.000224	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PDHA1—stomach cancer	1.83e-05	0.000224	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ECHS1—stomach cancer	1.83e-05	0.000224	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTT1—stomach cancer	1.83e-05	0.000224	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2A6—stomach cancer	1.81e-05	0.000221	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKR1C3—stomach cancer	1.76e-05	0.000215	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TYMP—stomach cancer	1.72e-05	0.00021	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—FADS1—stomach cancer	1.72e-05	0.00021	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.72e-05	0.00021	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ENO1—stomach cancer	1.72e-05	0.00021	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.69e-05	0.000206	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CD44—stomach cancer	1.67e-05	0.000204	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CD44—stomach cancer	1.63e-05	0.000199	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.62e-05	0.000198	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SREBF2—stomach cancer	1.61e-05	0.000197	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—RORA—stomach cancer	1.59e-05	0.000195	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CD44—stomach cancer	1.52e-05	0.000186	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDOB—stomach cancer	1.49e-05	0.000182	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.48e-05	0.00018	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPP2R1A—stomach cancer	1.42e-05	0.000173	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTP1—stomach cancer	1.39e-05	0.00017	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALOX5—stomach cancer	1.39e-05	0.000169	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.39e-05	0.000169	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HMOX1—stomach cancer	1.37e-05	0.000168	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—DPYD—stomach cancer	1.37e-05	0.000167	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTP1—stomach cancer	1.36e-05	0.000166	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HMOX1—stomach cancer	1.34e-05	0.000164	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TYMS—stomach cancer	1.3e-05	0.000158	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPP2R1A—stomach cancer	1.29e-05	0.000158	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTM1—stomach cancer	1.28e-05	0.000156	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTP1—stomach cancer	1.27e-05	0.000155	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TYMS—stomach cancer	1.26e-05	0.000154	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HMOX1—stomach cancer	1.25e-05	0.000153	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTM1—stomach cancer	1.25e-05	0.000152	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTT1—stomach cancer	1.21e-05	0.000147	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ERCC2—stomach cancer	1.2e-05	0.000147	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.19e-05	0.000146	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TYMS—stomach cancer	1.18e-05	0.000144	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ERCC2—stomach cancer	1.17e-05	0.000143	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTM1—stomach cancer	1.17e-05	0.000142	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.16e-05	0.000142	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ENO1—stomach cancer	1.13e-05	0.000138	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTHFR—stomach cancer	1.13e-05	0.000138	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTHFR—stomach cancer	1.1e-05	0.000135	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ERCC2—stomach cancer	1.1e-05	0.000134	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CAV1—stomach cancer	1.04e-05	0.000127	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APOA1—stomach cancer	1.04e-05	0.000127	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTHFR—stomach cancer	1.03e-05	0.000126	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CAV1—stomach cancer	1.02e-05	0.000124	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOA1—stomach cancer	1.02e-05	0.000124	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CD44—stomach cancer	1e-05	0.000123	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.97e-06	0.000122	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CAV1—stomach cancer	9.52e-06	0.000116	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOA1—stomach cancer	9.49e-06	0.000116	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPARG—stomach cancer	9.17e-06	0.000112	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.09e-06	0.000111	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPARG—stomach cancer	8.95e-06	0.000109	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	8.54e-06	0.000104	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTP1—stomach cancer	8.38e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPARG—stomach cancer	8.37e-06	0.000102	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HMOX1—stomach cancer	8.26e-06	0.000101	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALB—stomach cancer	8.25e-06	0.000101	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALB—stomach cancer	8.05e-06	9.82e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NOS3—stomach cancer	7.89e-06	9.63e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TYMS—stomach cancer	7.79e-06	9.5e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NOS3—stomach cancer	7.7e-06	9.4e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTM1—stomach cancer	7.7e-06	9.39e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALB—stomach cancer	7.52e-06	9.18e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ERCC2—stomach cancer	7.24e-06	8.83e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS2—stomach cancer	7.22e-06	8.8e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NOS3—stomach cancer	7.19e-06	8.78e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS2—stomach cancer	7.04e-06	8.59e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTHFR—stomach cancer	6.8e-06	8.3e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS2—stomach cancer	6.58e-06	8.03e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CAV1—stomach cancer	6.28e-06	7.66e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOA1—stomach cancer	6.26e-06	7.64e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPARG—stomach cancer	5.52e-06	6.73e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALB—stomach cancer	4.96e-06	6.05e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NOS3—stomach cancer	4.75e-06	5.79e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CA—stomach cancer	4.44e-06	5.42e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS2—stomach cancer	4.34e-06	5.29e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CA—stomach cancer	4.33e-06	5.29e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CA—stomach cancer	4.05e-06	4.94e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.67e-06	3.26e-05	CbGpPWpGaD
